University of California – San Francisco


University of California – San Francisco (UCSF) has established a collaborative partnership with multiple universities in the U.S., designating itself as a premier study site for visits. This strategic alliance brings together the research expertise of all institutions, fostering a dedicated environment for the investigation and understanding of CADASIL. Through joint efforts, UCSF and the entire Consortium of sites aim to advance knowledge and contribute to the broader scientific community’s understanding of this rare and complex condition.

Michael Geschwind

Position title: Site Principal Investigator


Dr. Geschwind received his MD and PhD degrees in neuroscience through the National Institutes of Health (NIH)-sponsored Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles (UCLA) Medical Center, his neurology residency at the Johns Hopkins University School of Medicine in Baltimore and his fellowship in behavioral neurology at the UCSF Memory and Aging Center (MAC). He is a Professor of Neurology at the MAC.

Iman Fathai

Position title: Clinical Research Coordinator


Iman graduated in May of 2022 from the University of Pennsylvania with a degree in Biology and minor in Bioethics. She plans on pursuing medical school in the upcoming year and is highly interested in the field of neurology. Her favorite aspect about being involved in the CADASIL Consortium study is being able to directly interact with those affected by this rare disease and contributing to the development of treatments for CADASIL.